These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1885 related items for PubMed ID: 26427793
1. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4. Doddapattar P, Gandhi C, Prakash P, Dhanesha N, Grumbach IM, Dailey ME, Lentz SR, Chauhan AK. Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793 [Abstract] [Full Text] [Related]
2. Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice. Doddapattar P, Jain M, Dhanesha N, Lentz SR, Chauhan AK. Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):500-508. PubMed ID: 29326316 [Abstract] [Full Text] [Related]
3. Differential Roles of Endothelial Cell-Derived and Smooth Muscle Cell-Derived Fibronectin Containing Extra Domain A in Early and Late Atherosclerosis. Doddapattar P, Dev R, Jain M, Dhanesha N, Chauhan AK. Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1738-1747. PubMed ID: 32434411 [Abstract] [Full Text] [Related]
4. Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient mice. Pulakazhi Venu VK, Uboldi P, Dhyani A, Patrini A, Baetta R, Ferri N, Corsini A, Muro AF, Catapano AL, Norata GD. Thromb Haemost; 2015 Jul; 114(1):186-97. PubMed ID: 25881051 [Abstract] [Full Text] [Related]
5. Genetic Ablation of Extra Domain A of Fibronectin in Hypercholesterolemic Mice Improves Stroke Outcome by Reducing Thrombo-Inflammation. Dhanesha N, Ahmad A, Prakash P, Doddapattar P, Lentz SR, Chauhan AK. Circulation; 2015 Dec 08; 132(23):2237-47. PubMed ID: 26508731 [Abstract] [Full Text] [Related]
6. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering. Yu P, Xiong T, Tenedero CB, Lebeau P, Ni R, MacDonald ME, Gross PL, Austin RC, Trigatti BL. Arterioscler Thromb Vasc Biol; 2018 Jan 08; 38(1):26-39. PubMed ID: 29162602 [Abstract] [Full Text] [Related]
12. Deletion of Extra Domain A of Fibronectin Reduces Acute Myocardial Ischaemia/Reperfusion Injury in Hyperlipidaemic Mice by Limiting Thrombo-Inflammation. Chorawala MR, Prakash P, Doddapattar P, Jain M, Dhanesha N, Chauhan AK. Thromb Haemost; 2018 Aug 08; 118(8):1450-1460. PubMed ID: 29960272 [Abstract] [Full Text] [Related]
13. Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells. Dietrich T, Hucko T, Schneemann C, Neumann M, Menrad A, Willuda J, Atrott K, Stibenz D, Fleck E, Graf K, Menssen HD. Atherosclerosis; 2012 Feb 08; 220(2):329-36. PubMed ID: 22062588 [Abstract] [Full Text] [Related]
14. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice. Doddapattar P, Dhanesha N, Chorawala MR, Tinsman C, Jain M, Nayak MK, Staber JM, Chauhan AK. Arterioscler Thromb Vasc Biol; 2018 Mar 08; 38(3):520-528. PubMed ID: 29348121 [Abstract] [Full Text] [Related]
15. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta. Butcher MJ, Waseem TC, Galkina EV. Arterioscler Thromb Vasc Biol; 2016 Aug 08; 36(8):1496-506. PubMed ID: 27365405 [Abstract] [Full Text] [Related]
16. P-Selectin Expressed by a Human SELP Transgene Is Atherogenic in Apolipoprotein E-Deficient Mice. Zhang N, Liu Z, Yao L, Mehta-D'souza P, McEver RP. Arterioscler Thromb Vasc Biol; 2016 Jun 08; 36(6):1114-21. PubMed ID: 27102967 [Abstract] [Full Text] [Related]
17. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE-/- mice and inhibits monocyte/macrophage recruitment. Xiong W, Wang X, Dai D, Zhang B, Lu L, Tao R. Thromb Haemost; 2017 Jan 26; 117(2):401-414. PubMed ID: 27831589 [Abstract] [Full Text] [Related]
18. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice. Jiang H, Li X, Zhang X, Liu Y, Huang S, Wang X. Cardiovasc Pathol; 2014 Jan 26; 23(3):169-74. PubMed ID: 24561077 [Abstract] [Full Text] [Related]
19. Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein E. Hsu CC, Paik J, Brabb TL, O'Brien KD, Kim J, Sullivan BG, Hudkins KL, Seamons A, Finley JC, Meeker SM, Maggio-Price L. Comp Med; 2015 Oct 26; 65(5):369-81. PubMed ID: 26473341 [Abstract] [Full Text] [Related]
20. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice. Zhang W, Tang T, Nie D, Wen S, Jia C, Zhu Z, Xia N, Nie S, Zhou S, Jiao J, Dong W, Lv B, Xu T, Sun B, Lu Y, Li Y, Cheng L, Liao Y, Cheng X. Cardiovasc Res; 2015 Jun 01; 106(3):453-64. PubMed ID: 25784693 [Abstract] [Full Text] [Related] Page: [Next] [New Search]